The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring.
 
Zachary Rivers
Employment - Tempus AI
Stock and Other Ownership Interests - Tempus AI
Research Funding - Bayer; Tempus AI
Travel, Accommodations, Expenses - Tempus AI
 
Charu Aggarwal
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; Novocure; Pfizer; Sanofi/Regeneron; Takeda
Speakers' Bureau - AstraZeneca (I); Roche/Genentech (I)
Research Funding - AstraZeneca/MedImmune (Inst); Candel Therapeutics (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Loxo@Lilly (Inst); Merck Sharp & Dohme (Inst)
 
Marc Ryan Matrana
Consulting or Advisory Role - AstraZeneca; Strata Oncology
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Eisai; Exelixis; Genentech; Janssen; Merck; Seagen
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca; bristol myers; Coherus Biosciences; daichi; Genentech; Janssen; Lilly; Lilly; Merck; Pfizer; regeneron
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); bms (Inst); Bristol Myers (Inst); genentech; Merck; Pfizer (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Akash Mitra
Employment - Guardant Health; Tempus
Stock and Other Ownership Interests - Guardant Health; Tempus
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus AI
Stock and Other Ownership Interests - Abbvie
 
Rotem Ben-Shachar
Employment - Myriad Genetics; Tempus AI
Stock and Other Ownership Interests - Myriad Genetics; Tempus
 
Cathy Eng
Consulting or Advisory Role - Abbvie; Amgen (I); California Institute for Regenerative Medicine (CIRM) (I); Hookipa Biotech; IgM Biosciences (I); Merck Serono; Pfizer; Seagen; Taiho Oncology (I); Takeda
Research Funding - Gritstone Bio (Inst); Hutchison MediPharma (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
 
Sheetal Mehta Kircher
Stock and Other Ownership Interests - Abbott/AbbVie